Company
ChinaBrightGene Pharmaceutical Co., Ltd.(Jiangyun Road), China – FDA Inspections
Inspection records and compliance data for BrightGene Pharmaceutical Co., Ltd.(Jiangyun Road). 1 FDA inspection on record, 1 Form 483, last inspected January 25, 2024.
Company Profile
This profile covers BrightGene Pharmaceutical Co., Ltd.(Jiangyun Road) based in China.
FDA Inspection History
- FDA inspections
- 1
- OAI
- 0
- VAI
- 0
- NAI
- 0
- Unclassified
- 1
- Form 483s
- 1
- Warning letters
- 0
Inspected January 25, 2024.
FDA inspections (1)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| January 25, 2024 | Not classified | Human Drugs | 1227980 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Pharmadax (Foshan) Co., Ltd.
Luoxin Aurovitas Pharma (Chengdu) Co., Ltd.
Tianjin Kingyork Pharmaceuticals Co., Ltd
Beijing Sciecure Pharmaceutical Co Ltd
Hainan Hailing Chemipharma Corporation Limited
Zydus Pharmaceuticals Limited
Ethypharm
Horizon Therapeutics Ireland Designated Activity Company (DAC)
NIPRO PHARMA CORPORATION
Avista Pharma Solutions, Inc. dba Cambrex
Company Information
Name
BrightGene Pharmaceutical Co., Ltd.(Jiangyun Road)
FEI Number
3023102835
Address
China
Country
China
ID: fee25d1b-c470-4be1-8b02-9ffa6e044007